ADP’s Q4 FY’25 Results Beat Expectations with $2.23 EPS
ADP's fourth quarter performance exceeded expectations with a notable increase in revenue and earnings per share.
BTC$60,691.00+2.36%
ETH$1,629.81+1.98%
USDT$0.9988+0.02%
USDC$0.9997+0.00%
XRP$1.06+1.21%
SOL$78.11+3.35%
TRX$0.3159-0.12%
FIGR_HELOC$1.03+1.32%
HYPE$63.62-3.34%
DOGE$0.0731+0.95%
RAIN$0.0156-0.60%
USDS$0.9996+0.01%
LEO$9.18-0.86%
ZEC$421.55+3.28%
XLM$0.1991-1.17%
BTC$60,691.00+2.36%
ETH$1,629.81+1.98%
USDT$0.9988+0.02%
USDC$0.9997+0.00%
XRP$1.06+1.21%
SOL$78.11+3.35%
TRX$0.3159-0.12%
FIGR_HELOC$1.03+1.32%
HYPE$63.62-3.34%
DOGE$0.0731+0.95%
RAIN$0.0156-0.60%
USDS$0.9996+0.01%
LEO$9.18-0.86%
ZEC$421.55+3.28%
XLM$0.1991-1.17%
Altria's Q2 2025 results show a decline in net revenues yet an improvement in adjusted EPS, surpassing expectations.
ADP's fourth quarter performance exceeded expectations with a notable increase in revenue and earnings per share.
Humana Inc. reports second quarter 2025 financial results with earnings per share (EPS) slightly below expectations.
Fundamental Global announces $200 million private placement to launch Ethereum treasury strategy, causing stock to surge 76.66% in premarket trading.
For near-future practical quantum computing, these companies offer relatives safe exposure. And some more than others.
Novo Nordisk stock crashed over 20% in premarket trading after the company cut its 2025 forecast for the second time.
Procter & Gamble has posted a solid performance in the fourth quarter of 2025, with net sales and earnings per share exceeding expectations.
UnitedHealth Group shares fell over 5% in premarket trading after missing Q2 earnings expectations and providing disappointing 2025 guidance.
Merck's second-quarter performance showed a slight decline in sales compared to the previous year.
UnitedHealth Group's second-quarter results showed a revenue increase but a decline in earnings per share compared to expectations.
VAPE stock surged in premarket trading following the announcement of a PIPE offering to establish the world's largest publicly listed BNB treasury strategy.
Celcuity's stock surged over 112% in premarket trading following positive Phase 3 trial results for its breast cancer treatment, marking a potential breakthrough in targeted cancer…
Alliance Resource Partners reported a decrease in revenue and net income for Q2 2025, falling short of analyst expectations.